Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Exogenesis Corporation is a biomedical technology company specializing in the surface modification of medical devices using its proprietary Accelerated Neutral Atom Beam (ANAB) technology. The ANAB platform allows for the precise, atomic-level engineering of implant surfaces to improve bio-integration and reduce adverse biological responses without altering the bulk material properties. The company's primary focus is on enhancing orthopedic implants, such as PEEK spinal fusion devices, and soft tissue repair products like hernia meshes. By creating "bio-active" surfaces, Exogenesis aims to improve clinical outcomes and patient recovery across multiple medical disciplines, including orthopedics, cardiology, and ophthalmology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Exogenesis Corporation.